Literature DB >> 29600015

Heart-breaking aspirin interruption.

Michel Zeitouni1, Gilles Montalescot1.   

Abstract

Entities:  

Year:  2018        PMID： 29600015      PMCID： PMC5863190          DOI： 10.21037/jtd.2017.12.42

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  26 in total

1.  Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Authors:  Christopher P Cannon; Deepak L Bhatt; Jonas Oldgren; Gregory Y H Lip; Stephen G Ellis; Takeshi Kimura; Michael Maeng; Bela Merkely; Uwe Zeymer; Savion Gropper; Matias Nordaby; Eva Kleine; Ruth Harper; Jenny Manassie; James L Januzzi; Jurrien M Ten Berg; P Gabriel Steg; Stefan H Hohnloser
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

2.  Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial.

Authors:  Yoshihiko Saito; Sadanori Okada; Hisao Ogawa; Hirofumi Soejima; Mio Sakuma; Masafumi Nakayama; Naofumi Doi; Hideaki Jinnouchi; Masako Waki; Izuru Masuda; Takeshi Morimoto
Journal:  Circulation       Date:  2016-11-15       Impact factor: 29.690

3.  Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.

Authors:  Roxana Mehran; Usman Baber; Philippe Gabriel Steg; Cono Ariti; Giora Weisz; Bernhard Witzenbichler; Timothy D Henry; Annapoorna S Kini; Thomas Stuckey; David J Cohen; Peter B Berger; Ioannis Iakovou; George Dangas; Ron Waksman; David Antoniucci; Samantha Sartori; Mitchell W Krucoff; James B Hermiller; Fayaz Shawl; C Michael Gibson; Alaide Chieffo; Maria Alu; David J Moliterno; Antonio Colombo; Stuart Pocock
Journal:  Lancet       Date:  2013-09-01       Impact factor: 79.321

4.  Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.

Authors: 
Journal:  Lancet       Date:  1998-01-24       Impact factor: 79.321

5.  A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Authors:  Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

6.  Perioperative Aspirin for Prevention of Venous Thromboembolism: The PeriOperative ISchemia Evaluation-2 Trial and a Pooled Analysis of the Randomized Trials.

Authors:  John W Eikelboom; Clive Kearon; Gordon Guyatt; Daniel I Sessler; Salim Yusuf; Deborah Cook; James Douketis; Ameen Patel; Andrea Kurz; Rene Allard; Philip M Jones; Rodolfo J Dennis; Thomas W Painter; Sergio D Bergese; Kate Leslie; Duminda N Wijeysundera; Kumar Balasubramanian; Emmanuelle Duceppe; Scott Miller; Johan Diedericks; P J Devereaux
Journal:  Anesthesiology       Date:  2016-12       Impact factor: 7.892

7.  Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.

Authors:  Jeffrey S Berger; Mori J Krantz; John M Kittelson; William R Hiatt
Journal:  JAMA       Date:  2009-05-13       Impact factor: 56.272

8.  Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.

Authors:  C Michael Gibson; Roxana Mehran; Christoph Bode; Jonathan Halperin; Freek W Verheugt; Peter Wildgoose; Mary Birmingham; Juliana Ianus; Paul Burton; Martin van Eickels; Serge Korjian; Yazan Daaboul; Gregory Y H Lip; Marc Cohen; Steen Husted; Eric D Peterson; Keith A Fox
Journal:  N Engl J Med       Date:  2016-11-14       Impact factor: 91.245

9.  The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

Authors:  Jill Belch; Angus MacCuish; Iain Campbell; Stuart Cobbe; Roy Taylor; Robin Prescott; Robert Lee; Jean Bancroft; Shirley MacEwan; James Shepherd; Peter Macfarlane; Andrew Morris; Roland Jung; Christopher Kelly; Alan Connacher; Norman Peden; Andrew Jamieson; David Matthews; Graeme Leese; John McKnight; Iain O'Brien; Colin Semple; John Petrie; Derek Gordon; Stuart Pringle; Ron MacWalter
Journal:  BMJ       Date:  2008-10-16

10.  β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction.

Authors:  Tatendashe B Dondo; Marlous Hall; Robert M West; Tomas Jernberg; Bertil Lindahl; Hector Bueno; Nicolas Danchin; John E Deanfield; Harry Hemingway; Keith A A Fox; Adam D Timmis; Chris P Gale
Journal:  J Am Coll Cardiol       Date:  2017-06-06       Impact factor: 27.203
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.